Bär & Karrer has represented a former UEFA ethics and disciplinary inspector before the Swiss Federal Supreme Court. In this sense, two former UEFA ethics and disciplinary inspectors have been acquitted in a lawsuit against the former president of a European football club and another person close to the club. The Swiss Federal Supreme Court […]
The Swiss Federal Patent Court held Bayer’s patent to be preliminarily valid and – in particular – confirmed the existence of inventive step. The court granted a preliminary injunction prohibiting generic company Helvepharm from distributing its
Lenz & Staehelin advised the Geneva opera, the Grand Théatre de Genève, in connection with a dispute over the sale of the Opera des Nations, a wooden structure belonging to the opera. A
MLL’s patent team successfully represented Swisscom Switzerland in a patent infringement claim of a non-practicing entity directed at Swisscom’s product “Swisscom TV 2.0”, in particular the technology that allows specific parts of programs to
International law firm Baker & McKenzie has been representing platinum group metal recycling company, Johnson Matthey and its Swiss subsidiary in its five-year fight against an order of the Federal Tax Administration (FTA) claiming additional
In a decision dated 14 February 2022 and notified on 3 March 2022 (case 4A_406/2021), the Swiss Supreme Court (“the Court”) dismissed the setting-aside application filed by the Chinese Olympic swimmer Sun Yang against an arbitral award rendered by
MLL successfully represented an Icelandic subcontractor before the Commercial Court of the Canton of Zurich. The dispute related to the construction of a Si-Metal construction plant in Iceland, for which the subcontractor had provided certain
Lenz & Staehelin , led by partner Benoît Merkt (pictured) and includes associate Johana Cau (competition), represented Dargaud in an appeal before the Swiss Supreme Court against a judgment by the Swiss Administrative Court on 30
On December 15, 2021, Homburger successfully enforced Novartis’ deferasirox patents before the Swiss Federal Patent Court. The Court handed down a preliminary injunction judgment prohibiting Mepha Pharma from marketing a generic version of Novartis’ drug Jadenu® in
MLL successfully represented an international investment fund before the Swiss Federal Supreme Court in a dispute for director’s liability against a former director of the fund administrator. The investment fund had filed an action